Abstract

Heart disease remains the leading cause of mortality globally, so further investigation is required to identify its underlying mechanisms and potential targets for treatment and prevention. Mitsugumin 53 (MG53), also known as TRIM72, is a TRIM family protein that was found to be involved in cell membrane repair and primarily found in striated muscle. Its role in skeletal muscle regeneration and myogenesis has been well documented. However, accumulating evidence suggests that MG53 has a potentially protective role in heart tissue, including in ischemia/reperfusion injury of the heart, cardiomyocyte membrane injury repair, and atrial fibrosis. This review summarizes the regulatory role of MG53 in cardiac tissues, current debates regarding MG53 in diabetes and diabetic cardiomyopathy, as well as highlights potential clinical applications of MG53 in treating cardiac pathologies.

Details

Title
Cardiac effects and clinical applications of MG53
Author
Zhong, Weina; Benissan-Messan, Dathe Z; Ma, Jianjie; Cai, Chuanxi  VIAFID ORCID Logo  ; Lee, Peter H U
Pages
1-10
Section
Review
Publication year
2021
Publication date
2021
Publisher
BioMed Central
e-ISSN
20453701
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2553305313
Copyright
© 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.